TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Hua Medicine ( (HK:2552) ) is now available.
Hua Medicine announced the grant of 9,700,000 share options to its executive directors, employees, and a service provider, under its share option scheme. This move is aimed at recognizing the outstanding performance of its team in achieving critical milestones in 2024, reinforcing their commitment to the company’s long-term growth and development.
More about Hua Medicine
Hua Medicine is a pharmaceutical company focused on the development and commercialization of innovative therapies for diabetes. The company is known for its efforts in advancing diabetes treatment solutions and has a market focus on addressing unmet medical needs in this area.
Technical Sentiment Signal: Buy
Current Market Cap: $321.9M
For detailed information about 2552 stock, go to TipRanks’ Stock Analysis page.